Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTION-1: ACT Guided Heparinization in Open AAA Repair
NCT04061798Phase 4Terminated
- Sponsor
- Dijklander Ziekenhuis
- Start
- Mar 2020
- Primary completion
- Apr 2024
- Countries
- 2
01
Overview
Phase 4, randomised, single-blind trial of heparin in abdominal aortic aneurysm (AAA) (2 arms), sponsored by Dijklander Ziekenhuis. Primary endpoint: Combined incidence of all thrombo-embolic complications (TEC) and all-cause mortality at 30 days. Started Mar 2020; status: terminated.
02
Drugs
heparin
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT04061798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04061798.